The weekly litigation news digest is live. Subscribe now

IP Verse

Animal Models And Therapeutic Molecules - EP2792236

The patent EP2792236 was granted to Kymab on Mar 22, 2023. The application was filed on Jul 7, 2010 under application number EP14176740A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2792236

KYMAB
Application Number
EP14176740A
Filing Date
Jul 7, 2010
Status
Patent Maintained As Amended
Feb 17, 2023
Publication Date
Mar 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
REGENERON PHARMACEUTICALSAug 14, 2018J A KEMPADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONDE10251918
EXAMINATIONGB2403475
OPPOSITIONDE10251918
OPPOSITIONGB2403475
OPPOSITIONUS2009093059
OPPOSITIONUS7205148
OPPOSITIONWO02066630
OPPOSITIONWO2008081197
OPPOSITIONWO2009013620
OPPOSITIONWO2009076464
SEARCHWO02059263
SEARCHWO02066630
SEARCHWO03006639
SEARCHWO2005004592
SEARCHWO2009076464

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents